Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.
The outer membrane protein CD of Moraxella catarrhalis is considered to be a potential vaccine antigen against Moraxella infection. We purified the native CD from isolate O35E, administered it to mice, and detected considerable titers of anti-CD antibodies. Anti-CD sera were cross-reactive towards six different M. catarrhalis isolates and promoted bacterial clearance of O35E in a pulmonary challenge model. To circumvent the difficulty of generating large quantities of CD from M. catarrhalis for vaccine use, the CD gene from O35E was cloned into Escherichia coli, and the recombinant CD, expressed without a signal sequence or fusion tags, represented approximately 70% of the total E. coli proteins. The recombinant CD formed inclusion bodies that were solubilized with 6 M urea and then purified by ion-exchange chromatography, a procedure that produced soluble CD of high purity and yield. Mice immunized with the purified recombinant CD had significant titers of anti-CD antibodies that were cross-reactive towards 24 different M. catarrhalis isolates. Upon challenge, these mice showed enhanced bacterial clearance of both O35E and a heterologous M. catarrhalis isolate, TTA24. In an in vitro assay, antisera to either the native or the recombinant CD inhibited the binding activity of CD to human tracheobronchial mucin in a serum concentration-dependent manner, and the extent of inhibition appeared to correlate with the corresponding anti-CD antibody titer and whole-cell enzyme-linked immunosorbent assay titer. Our results demonstrate that the recombinant CD is a promising vaccine candidate for preventing Moraxella infection.
Liu
Dai-Fang
DF
Wyeth Vaccines Research, 401 N. Middletown Road 205/281, Pearl River, NY 10965, USA. liudf@wyeth.com
McMichael
John C
JC
Baker
Steven M
SM
D018829:Adhesins, Bacterial / Q000276:immunology* / Q000302:isolation & purification; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D008168:Lung / Q000276:immunology* / Q000382:microbiology; D051379:Mice; D018345:Mice, Knockout; D001936:Moraxella catarrhalis / Q000737:chemistry* / Q000276:immunology; D009077:Mucins / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism
D018829:Adhesins, Bacterial; D000907:Antibodies, Bacterial; D009077:Mucins; D011993:Recombinant Fusion Proteins; C484698:outer membrane protein CD, Moraxella catarrhalis